FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

764274008: Ertugliflozin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3647251017 Ertugliflozin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647252012 Ertugliflozin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ertugliflozin Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Ertugliflozin Has disposition (attribute) Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Ertugliflozin Is a Diphenylmethane true Inferred relationship Some
Ertugliflozin Is a Drug or medicament (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ertugliflozin (medicinal product) Has active ingredient True Ertugliflozin Inferred relationship Some 1
Product containing ertugliflozin in oral dose form (medicinal product form) Has active ingredient True Ertugliflozin Inferred relationship Some 1
Product containing only ertugliflozin (medicinal product) Has active ingredient True Ertugliflozin Inferred relationship Some 1
Product containing only ertugliflozin in oral dose form (medicinal product form) Has active ingredient True Ertugliflozin Inferred relationship Some 1
Ertugliflozin pidolate Is modification of (attribute) True Ertugliflozin Inferred relationship Some
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Ertugliflozin Inferred relationship Some 1
Ertugliflozin (as ertugliflozin pidolate) 5 mg oral tablet Has basis of strength substance (attribute) True Ertugliflozin Inferred relationship Some 1
Allergy to ertugliflozin Causative agent True Ertugliflozin Inferred relationship Some 1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Ertugliflozin Inferred relationship Some 2
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Ertugliflozin Inferred relationship Some 2
Product containing only ertugliflozin and sitagliptin in oral dose form (medicinal product form) Has active ingredient True Ertugliflozin Inferred relationship Some 2
Ertugliflozin- and sitagliptin-containing product Has active ingredient True Ertugliflozin Inferred relationship Some 2
Ertugliflozin- and sitagliptin-containing product in oral dose form Has active ingredient True Ertugliflozin Inferred relationship Some 2
Product containing only ertugliflozin and sitagliptin (medicinal product) Has active ingredient True Ertugliflozin Inferred relationship Some 2
Adverse reaction caused by ertugliflozin (disorder) Causative agent True Ertugliflozin Inferred relationship Some 1

This concept is not in any reference sets

Back to Start